Loading video...

Video Failed to Load

Go Home

šŸ¦•šŸ¦–ā€œOver time we’ll know enough about DNA that we could probably engineer dinosaur-like stuff.ā€ Got your attention? Colossal Co-Founder and CEO Ben Lamm drops some facts about dinosaur de-extinction.

15,503 views • 10 months ago •via X (Twitter)

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

BREAKING: Inside $12 Billion Colossal BiosciencesĀ® Biosciences + Colossal Spinout 'Astromech' Announces $20M Raise at $3.8 Billion Woolly Mice, Dire Wolves, & AI-Driven Biotech "We are one of the most undervalued companies in the world." "[AI x Biotech] is truly exploding. You're gonna see this Precambrian explosion of new drugs & new therapies that all come from AI-assisted drug design & discovery." Co-Founder & CEO Ben Lamm Up to 50% of all biodiversity is forecast to be lost in the next 25 years. Asian elephants get cancer at 2% to 3%, humans at 24% to 25%. That gap is the thesis behind both companies. Colossal has raised $635M in total to date. CEO Lamm says each round was 2X oversubscribed, including a most recent round planned for $200M that closed at $400M. Six target species, 260-plus employees, 55,000 sqft Texas HQ, & no animal has ever been sold. Astromech is the AI-driven predictive biology startup spun out of Colossal that aims to forecast how biological systems, evolution, & diseases will change over time. Astromech has raised $60M total. $30M in 2025, a $10.5M extension reported in April, & now $20M led by Bob Nelsen with Peak 6, NeoGenesis Capital, Builders VC, & CAZ Investments. Valuation moved from $2B in March to $3.8B today. Co-founded by Lamm & George Church. On the spinouts: "When new ideas & technologies arise that have other applications outside of de-extinction & species preservation, we spin them out or license the technology so our core teams can focus on Colossal's mission." Colossal Spinouts: › Form Bio, 2022, computational life sciences platform › Breaking, plastic degradation using Colossal bioengineering › Astromech, 2026, evolutionary AI › Artificial wombs, next in line, tech expected ready in ~2027, with human fertility applications We cover: › Astromech, AI for Biology › Gene drives, screwworm, and a half trillion dollar invasive species market › Woolly mice from edit design to live animals in 30 days › The Viagen acquisition and 80% cloning efficiency › Artificial wombs, IVF, & germline applications › $635M raised & why every round was oversubscribed › The no-go list on human and primate work š“šˆšŒš„š’š“š€šŒšš’ (00:00) Ben Lamm, Co-Founder & CEO at Colossal Biosciences (01:07) Inside Colossal's De-Extinction Lab (05:07) Every wall in this lab has a purpose (06:02) The AI idea that could save the planet (08:09) What Colossal is building next (08:28) Revealing Colossal's woolly mice (10:49) Wild requests they get every day (13:35) Colossal's business model (15:07) How Colossal raised $635 million (20:17) How AI is converging with Biotech (22:44) How ancient DNA actually gets to the lab (26:24) The real stats behind Mass Extinction (32:07) Will their animals ever live in the wild? (34:58) Building this company with no background in Biology (41:44) Choosing their earliest backers (52:51) Why they refuse to work on Humans (58:07) Are they secretly working on Aliens?

Molly O’Shea

251,681 views • 1 month ago